TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Danamedicus AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,616
|
1,464
|
1,275 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
655
|
513
|
372 |
EBITDA |
621
|
501
|
363 |
Total assets |
2,182
|
1,912
|
1,853 |
Current assets |
2,182
|
1,912
|
1,853 |
Current liabilities |
134
|
103
|
139 |
Equity capital |
1,963
|
1,729
|
1,660 |
- share capital |
51
|
47
|
49 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.0%
|
90.4%
|
89.6% |
Turnover per employee |
808
|
732
|
638 |
Profit as a percentage of turnover |
40.5%
|
35.0%
|
29.2% |
Return on assets (ROA) |
30.0%
|
26.8%
|
20.1% |
Current ratio |
1628.4%
|
1856.3%
|
1333.1% |
Return on equity (ROE) |
33.4%
|
29.7%
|
22.4% |
Change turnover |
48
|
228
|
-216 |
Change turnover % |
3%
|
18%
|
-15% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.